Abstract
Combining a DYRK1A inhibitor and GLP-1 receptor agonist boosts human pancreatic β cell proliferation and glucose homeostasis in vivo (Ackeifi et al., this issue).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have